Abstract
The hypothesis that the etiology of schizophrenia may involve a viral infection is certainly not new (Menninger, 1926). One refinement of the hypothesis has led to the concept that the disorder may involve an abnormal immune response, such as production of a central nervous system (CNS) autoantibody, perhaps following exposure to viral antigens (Knight, 1982). While the viral/immunologic hypothesis has generated decades of research, these investigations have failed to yield definitive evidence to support or refute the concept (DeLisi and Crow, 1986; Torrey and Kaufmann, 1986). Nevertheless, the rapid advances being made in understanding the molecular processes involved in viral pathogenesis and immune regulation are presenting dramatic new opportunities to test this hypothesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ahokas, A., Koskiniemi, M., Vaheri, A., and Rimón, R., 1985, Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders, Neuropsychobiology 14: 1–4.
Ahokas, A., Rimón, R. Koskiniemi, M., Vaheri, A., Julkunen, I., and Sarna, S., 1987, Viral antibodies and interferon in acute psychiatric disorders, J. Clin. Psychiatry 48: 194–196.
Axelsson, R., Martensson, E., and Ailing, C., 1982, Impairment of the blood—brain barrier as an aetiological factor in paranoid psychosis, Br. J. Psychiatry 141: 273–281.
Baker, H. F., Ridley, R.M., Crow, T. J., Bloxham, C. A., Parry, R. P. and Tyrrell, D. A. J., 1983, An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease, Psychol. Med. 13: 499–511.
Bauer, K., and Kornhuber, J., 1987, Blood—cerebrospinal fluid barrier in schizophrenic patients, Eur. Arch. Psychiatry Neurol. Sci. 236: 257–259.
Bigelow, L. B., and Berthot, B., 1989, The Psychiatric Symptom Assessment Scale (PSAS), Psychopharmacol. Bull. 25: 168–179.
Bock, E., and Rafaelsen, O. J., 1974, Schizophrenia: Proteins in blood and cerebrospinal fluid, Dan. Med. Bull. 21: 93–105.
Bruce, L. C., and Peebles, A. M. S., 1903, Clinical and experimental observations on catatonia, J. Ment. Sci. 49: 614–628.
Bruetsch, W L., Bahr, M. A., Skobba, J. S., and Dieter, W. J., 1942, The group of dementia praecox patients with an increase of the protein content of the cerebrospinal fluid, J. Nerv. Ment. Dis. 95: 669–679.
Co, M. S., Gaulton, G. N., Tominaga, A., Homcy, C. J., Fields, B. N., and Greene, M. I., 1985, Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors, Proc. Natl. Acad. Sci. USA 82: 5315–5318.
DeLisi, L. E., and Crow, T. J., 1986, Is schizophrenia a viral or immunologic disorder? Psychiatr. Clin. North Am. 9: 115–132.
DeLisi, L. E., Goodman, S., Neckers, L. M., and Wyatt, R. J., 1982, Lymphocyte subpopulations in schizophrenic patients, Biol. Psychiatry 17, 1003–1007.
Eaton, W W, 1985, Epidemiology of schizophrenia, Epidemiol. Rev. 7: 105–126.
Feenstra, A., Kirch, D. G., Coggiano, M. A., and Wyatt, R. J., 1988, Reverse transcriptase activity in 5-azacytidine-treated lymphocyte cultures of patients with schizophrenia, Schiz. Res. 1: 385–389.
Ganguli, R., and Rabin, B. S., 1989, Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects, Arch. Gen. Psychiatry 46: 292.
Grossberg, S. E., 1987, Interferons: An overview of their biological and biochemical properties, in: Mechanisms of Interfrron Actions, Volume I ( L. M. Pfeffer, ed.), CRC Press, Boca Raton, pp. 1–32.
Hirata-Hibi, M., Higashi, S., Tachibana, T., and Watanabi, N., 1982, Stimulated lymphocytes in schizophrenia, Arch. Gen. Psychiatry 39: 82–87.
Kaufmann, C. A., Weinberger, D. R., Yolken, R. H., Torrey, E. E, and Potkin, S. G., 1983, Viruses and schizophrenia, Lancet 2: 1136.
Kaufmann, C. A., Weinberger, D. R., Stevens, J. R., Asher, D. M., Kleinman, J. E., Sulima, M. P., Gibbs, C. J., and Gadjusek, D. C., 1988, Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia: Failure to observe consistent or specific behavioral and neuropathological effects, Arch. Gen. Psychiatry 45: 648–652.
Killingsworth, L. M., 1982, Clinical applications of protein determinations in biological fluids other than blood, Clin. Chem. (Winston-Salem, N.C.) 28: 1093–1102.
Kirch, D. G., and Weinberger, D. R., 1986, Anatomical neuropathology in schizophrenia: Post-mortem findings, in: The Neurology of Schizophrenia ( H. A. Nasrallah and D. R. Weinberger, eds.), Elsevier, Amsterdam, pp. 325–348.
Kirch, D. G., Kaufmann, C. A. Papadopoulos, N. M., Martin, B., and Weinberger, D. R., 1985
Abnormal cerebrospinal fluid protein indices in schizophrenia, Biol. Psychiatry 20, 1039–1046.
Knight, J. G., 1982, Dopamine-receptor-stimulating autoantibodies: A possible cause of schizophrenia, Lancet 2: 1073–1076.
Libikova, H., 1983, Schizophrenia and viruses: Principles of etiologic studies, in: Research on the Viral Hypothesis of Mental Disorders ( P. Morozov, ed.), Karger, Basel, pp. 20–51.
Link, H., and Tibbling, G., 1977, Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis, Scand. J. Clin. Lab. Invest. 37: 397–401.
Mednick, S. A., Machon, R. A., Huttunen, M. O., and Bonett, D., 1988, Adult schizophrenia following prenatal exposure to an influenza epidemic, Arch. Gen. Psychiatry 45: 189–192.
Menninger, K. A., 1919, Psychoses associated with influenza, J. Am. Med. Assoc. 72: 235–241.
Menninger, K. A., 1926, Influenza and schizophrenia: An analysis of post-influenzal “dementia praecox” as of 1918 and five years later, Am. J. Psychiatry 5: 469–529.
Moises, H. W., Schindler, L., Leroux, M., and Kirchner, H., 1985, Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients, Acta Psychiatr. Scand. 72: 42–50.
Moises, H. W, Beck, J., Schindler, L., and Kirchner, H., 1986, Decreased interferon in schizophrenic patients, Pharmacopsychiatry 19: 226–227.
Nyland, H., Naess, A., and Lunde, H., 1980, Lymphocyte subpopulations in peripheral blood from schizophrenic patients, Acta Psychiatr. Scand. 61: 313–318.
Oldstone, M. B. A., 1984, Viruses can alter cell function without causing cell pathology: Disordered function leads to imbalance of homeostasis and disease, in Concepts in Viral Pathogenesis (A. L. Notkins and M. B. A. Oldstone, eds.), Springer-Verlag, Berlin, pp. 269–276.
Overall, J. E., and Gorham, D. R., 1962, The Brief Psychiatric Rating Scale, Psychol. Rep. 10: 799–812.
Papadopoulos, N. M., Costello, R., Kay, A. D., Cutler, N. R., and Rapaport, S. I., 1984, Combined immunochemical and electrophoretic determinations of proteins in paired serum and cerebrospinal fluid samples, Clin. Chem. (Winston-Salem, N.C.) 30: 1814–1816.
Pearson, E. K., 1973, Study of cerebrospinal fluid in schizophrenics: A review of the literature, Psychopharmacol. Bull. 9: 59–62.
Preble, O. T., and Torrey, E. F., 1985, Serum interferon in patients with psychosis, Am. J. Psychiatry 142: 1184–1186.
Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., and Vilcek, J., 1982, Systemic lupus erythematosus: Presence in human serum of an unusual acid-labile leukocyte interferon, Science 216: 429–431.
Rapaport, M. H., McAllister, C. G., Pickar, D., Nelson, D. L., and Paul, S. M., 1989, Elevated levels of soluble interleukin 2 receptors in schizophrenia, Arch. Gen. Psychiatry 46: 291–292.
Rimón, R., and Ahokas, A., 1987, Interferon in schizophrenia, in: Viruses, Immunity, and Mental Disorders ( E. Kurstak, Z. J. Lipowski, and P. V. Morozov, eds.), Plenum Medical, New York, pp. 379–382.
Rimón, R., Halonen, P., Lebon, P., Heikkila, L., Frey, H., Karhula, P., Hintikka, J., and Salmela, L., 1983, Antibrain antibodies and interferon in the serum and cerebrospinal fluid of patients with schizophrenia, in: Research on the Viral Hypothesis of Mental Disorders ( P. Morozov, ed.), Karger, Basel, pp. 161–167.
Rimón, R., Ahokas, A., Hintikka, J., and Heikkila, L., 1985, Serum interferon in schizophrenia, Ann. Clin. Res. 17: 139–140.
Roos, R. P., Davis, K., and Meltzer, H. Y., 1985, Immunoglobulin studies in patients with psychiatric diseases, Arch. Gen. Psychiatry 42: 124–128.
Roy, A., Pickar, D., Ninan, P., Hooks, J., and Paul, S. M., 1985, A search for interferon in the CSF of chronic schizophrenic patients, Am. J. Psychiatry 142: 269.
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Ehrlich, H. E., 1988, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science 239: 487–491.
Schindler, L., Leroux, M., Beck, J., Moises, H. W, and Kirchner, H., 1986, Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients, Acta Psychiatr. Scand. 73: 651–657.
Stevens, J. R., 1982, Neuropathology of schizophrenia, Arch. Gen. Psychiatry 39: 1131–1139.
Suddath, R. L., Casanova, M. F., Goldberg, T. E., Daniel, D. G., Kelsoe, J. R., and Weinberger, D. R., 1989, Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study, Am. J. Psychiatry 146: 464–472.
Tibbling, G., Link, H., and Ohman, S., 1977, Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values, Scand. J. Clin. Lab. Invest. 37: 385–390.
Torrey, E. F., 1987, Prevalence studies in schizophrenia, Br. J. Psychiatry 150: 598–608.
Torrey, E. F., and Kaufmann, C. A., 1986, Schizophrenia and neuroviruses, in: The Neurology of Schizophrenia ( H. A. Nasrallah and D. R. Weinberger, eds.), Elsevier, Amsterdam, pp. 361–376.
Torrey, E. F., Albrecht, P., and Behr, D. E., 1985, Permeability of the blood—brain barrier in psychiatric patients, Am. J. Psychiatry 142: 657–658.
Tourtellotte, W. W, Potvin, A. R., Fleming, J. O., Murthy, K. N., Levy, J., Syndulko, K., and Potvin, J. H., 1980, Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate, Neurology 30: 240–244.
van Kammen, D. P., and Sternberg, D. E., 1980, Cerebrospinal fluid studies in schizophrenia, in: Neurobiology of Cerebrospinal Fluid ( J. H. Wood, ed.), Plenum Press, New York, pp. 719–742.
Wasley, G. D., and Wong, H. H. Y., 1988, Syphilis Serology: Principles and Practice, Oxford University Press, Oxford, pp. 1–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Publishing Corporation
About this chapter
Cite this chapter
Kirch, D.G., Wyatt, R.J. (1991). Interferon and Immunoglobulin G as Immunological Markers in Chronic Schizophrenia. In: Kurstak, E. (eds) Psychiatry and Biological Factors. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5811-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5811-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5813-8
Online ISBN: 978-1-4684-5811-4
eBook Packages: Springer Book Archive